Gamma knife radiosurgery for malignant melanoma brain metastases
- PMID: 9532412
Gamma knife radiosurgery for malignant melanoma brain metastases
Abstract
Purpose: To evaluate the efficacy and toxicity of gamma knife radiosurgery in the treatment of melanoma metastases to the brain.
Patients and methods: We retrospectively reviewed 55 patients with single or multiple intracranial melanoma metastases treated at the University of California, San Francisco, with gamma knife radiosurgery from 1991 through 1995. Sixteen patients were treated with gamma knife radiosurgery for recurrence following previous radiation therapy, 11 received radiosurgery as a boost to whole-brain radiation therapy, and 28 had radiosurgery alone for initial management of brain metastases. The median minimum radiosurgery tumor dose for 140 treated lesions was 19 Gy (range, 10-22 Gy) prescribed at the 35% to 90% isodose contour (median, 50%). The median total target volume per patient was 6.1 cc (range, 0.25-28.3 cc).
Results: With a median follow-up of 75 weeks in living patients, the median survival times were 35 weeks overall: 35 weeks for patients with solitary metastases versus 33 weeks for those with multiple metastases. A factor that was significant in univariate analysis of survival was total target volume treated. This parameter remained significant on multivariate analysis. The actuarial median freedom from progression analyzed by lesion for 113 lesions in 46 patients with imaging follow-up was 89 weeks with 6-month and 1-year actuarial freedom from progression rates of 89% (95% confidence interval, 80%-95%) and 77% (95% confidence interval, 62%-87%). In univariate analysis, improved freedom from progression was associated with smaller target volume treated, smaller maximum diameter, or higher prescribed dose. Four patients (7%) developed acute Radiation Therapy Oncology Group grade > or = 2 morbidity, and five patients (9%) developed late grade > or = 2 morbidity.
Discussion: Median survival and freedom from progression in patients treated with radiosurgery for melanoma metastatic to the brain are comparable to results in published radiosurgery series of grouped histologies. For melanoma patients, total intracranial tumor volume appears to be of greater prognostic significance than the absolute number of metastases treated. We conclude that gamma knife radiosurgery is effective and should be considered among various management strategies.
Comment in
-
Radiosurgery for metastases from malignant melanoma.Cancer J Sci Am. 1998 Mar-Apr;4(2):80-3. Cancer J Sci Am. 1998. PMID: 9532408 Review. No abstract available.
Similar articles
-
Gamma knife radiosurgery in the treatment of patients with single and multiple brain metastases from carcinoma of the breast.Cancer J. 2000 Mar-Apr;6(2):88-92. Cancer J. 2000. PMID: 11069225
-
The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1125-32. doi: 10.1016/j.ijrobp.2004.12.092. Int J Radiat Oncol Biol Phys. 2005. PMID: 15990018
-
Initial treatment of melanoma brain metastases using gamma knife radiosurgery: an evaluation of efficacy and toxicity.Cancer. 2004 Aug 15;101(4):825-33. doi: 10.1002/cncr.20447. Cancer. 2004. PMID: 15305416
-
The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):37-46. doi: 10.1016/j.ijrobp.2005.05.023. Int J Radiat Oncol Biol Phys. 2005. PMID: 16111570 Review.
-
[Hypofractionated stereotactic radiotherapy for brain metastases].Cancer Radiother. 2010 Apr;14(2):119-27. doi: 10.1016/j.canrad.2009.10.004. Epub 2009 Dec 8. Cancer Radiother. 2010. PMID: 20004125 Review. French.
Cited by
-
Tumor Primary Site and Histology Subtypes Role in Radiotherapeutic Management of Brain Metastases.Front Oncol. 2020 Jul 7;10:781. doi: 10.3389/fonc.2020.00781. eCollection 2020. Front Oncol. 2020. PMID: 32733787 Free PMC article. Review.
-
Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features.Neuro Oncol. 2008 Apr;10(2):199-207. doi: 10.1215/15228517-2007-058. Epub 2008 Feb 20. Neuro Oncol. 2008. PMID: 18287337 Free PMC article.
-
Successful treatment of melanoma brain metastases with adoptive cell therapy.Clin Cancer Res. 2010 Oct 1;16(19):4892-8. doi: 10.1158/1078-0432.CCR-10-1507. Epub 2010 Aug 18. Clin Cancer Res. 2010. PMID: 20719934 Free PMC article.
-
A Single-Institution Analysis of 126 Patients Treated with Stereotactic Radiosurgery for Brain Metastases.Front Oncol. 2017 May 12;7:90. doi: 10.3389/fonc.2017.00090. eCollection 2017. Front Oncol. 2017. PMID: 28553615 Free PMC article.
-
Clinical analysis of novalis stereotactic radiosurgery for brain metastases.J Korean Neurosurg Soc. 2009 Sep;46(3):245-51. doi: 10.3340/jkns.2009.46.3.245. Epub 2009 Sep 30. J Korean Neurosurg Soc. 2009. PMID: 19844626 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical